Last update 25 Oct 2025

Haematopoietic stem cell gene therapy(Novartis Pharma AG)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
CD34 anti-HIV gene therapy, CD34 anti-HIV therapy, CD34 gene therapy
+ [5]
Target
HIV integrase
Action
inhibitors
Mechanism
HIV-1 integrase inhibitors(HIV integrase inhibitors)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
HIV Infections
Originator Organization
Novartis Pharma AG
Active Organization-
Inactive Organization
Duke-NUS Graduate Medical School SingaporeDuke-NUS Graduate Medical School SingaporeNovartis Pharma AGSystemix, Inc.Systemix, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Haematopoietic stem cell gene therapy(Novartis Pharma AG)
Login to view more data
100 Translational Medicine associated with Haematopoietic stem cell gene therapy(Novartis Pharma AG)
Login to view more data
100 Patents (Medical) associated with Haematopoietic stem cell gene therapy(Novartis Pharma AG)
Login to view more data
100 Deals associated with Haematopoietic stem cell gene therapy(Novartis Pharma AG)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 2
United States
Systemix, Inc.Systemix, Inc.
-
HIV InfectionsPhase 2-
Duke-NUS Graduate Medical School SingaporeDuke-NUS Graduate Medical School Singapore
-
HIV InfectionsPhase 2-
Novartis Pharma AG
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free